Anti-VEGF for diabetic retinopathy: new perspectives

Objective: to consider the relevance and new directions for the use of anti-VEGF drugs in the treatment of diabetic retinopathy Methods: Literature review was carried out using PubMed, Cochrane Library search engines, an analysis of literature sources on a given topic published up to 2022 was performed. Abstract. Data is analyzed from recent studies designed to evaluate the use of anti-VEGF drugs in diabetic retinopathy with various conditions and with or without macular edema diabetes. Certain major promising directions are being invested in the field of anti-VEGF therapy.